Press Releases
Palleon Announces Issuance of a U.S. Patent for Use of Antibody Sialidase Conjugates
Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase
Palleon to Present on Phase 1/2 E-602 Bi-Sialidase Trial Design at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Palleon Co-Founder Dr. Carolyn Bertozzi Awarded Nobel Prize in Chemistry for Pioneering Methods of Studying Glycobiology
In the News
What A Nobel Prize-Winner’s Research Means for Cancer Treatment
MedCity News
Stanford’s Carolyn Bertozzi, 2022 Nobel Laureate in Chemistry, on translational science
Stanford School of Humanities and Sciences
Stanford’s Carolyn Bertozzi wins Nobel Prize in chemistry
Stanford
With details on lead sialoglycan degrader in place, Palleon raises $100M series B
BioCentury
Social Media
Our CSO, Li Peng, published an article in @medcitynews today that delves into the impact of @CarolynBertozzi's scie… http://BOHmxZzBoI
#BlackHistoryMonth highlights the value of diverse perspectives in all aspects of our world.
We encourage you to… http://gDbucoUM20